Medical device and MedTech insights, news, tips and more
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope in Europe
March 10, 2020
Hologic, Inc. (Nasdaq: HOLX) announced today that it has received a CE mark in Europe for its Omni™ hysteroscope, an innovative three-in-one modular scope with advanced visualization capabilities designed for both diagnostic and therapeutic hysteroscopic procedures. Obstetricians and gynecologists (ObGyns) can use the new Omni hysteroscope in out- and in-patient settings.
“Experts agree that direct visualization of the uterine cavity in women with abnormal uterine bleeding is the gold standard that allows ObGyns to accurately identify and collect quality samples and remove pathology – in a safer and more effective manner than blind biopsy and curettage,”1 said Edward Evantash, M.D., Medical Director and Vice President of Global Medical Affairs, Hologic. “Featuring three easily interchangeable sheaths in one scope, our new Omni scope gives ObGyns excellent visualization capabilities with the convenience of seeing and treating pathology in a more streamlined procedure.”
The Omni scope is designed to help ObGyns simplify the process of diagnosing and treating patients. Often, a surgeon requires a diagnostic scope to look in the uterine cavity for fibroids or polyps, then switches to an operative scope to biopsy or treat the pathology. With the new Omni scope, ObGyns can use the same scope with different sheath options to conveniently see and treat pathology.2
Additional features include:2
- Premium MyoSure optics for quality visualization and clarity throughout the procedure.
- Sheaths designed with smaller diameters (3.7 mm diagnostic sheath; 5.5 mm operative sheath; 6 mm operative sheath) to reduce dilation required and promote patient comfort and easy insertion.
- Long 200 mm working length facilitates easier access and treatment for obese patients.
- Simple assembly and disassembly so sheaths can be changed out easily between procedures.
- Operative sheaths can be used with Hologic’s Aquilex™ hysteroscopic fluid management system.
- Compatible with all MyoSure® tissue removal offerings including MyoSure REACH, MyoSure XL, MyoSure LITE, and MyoSure MANUAL devices.
“We continue to drive innovation designed with both our customers and the women they treat in mind,” said Jan Verstreken, Regional President, EMEA and Canada, Hologic. “Our customers are under pressure to deliver high-quality care to their patients in innovative ways. Our new Omni Hysteroscope provides them with a pioneering device that can treat a diverse range of patients.”
See Full Press Release: Hologic Receives CE Mark for Three-in-One Omni Hysteroscope in Europe | Business Wire
Written by: Hologic, Inc.
Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.
We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.
Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.